Strikingly, renal cysts were present in only 4/12 patients (33%) with NPHP1 mutations, while hyperechogenicity (7/10; 70%) and abnormal corticomedullary differentiation (3/8; 38%) were reported more frequently compared to the cohort average. This evidence concerns the gene NPHP1 and cystic kidney disease.